Efficacy and Cost-effectiveness of Different Caries Preventive Protocols

Sponsor
Roya mohamed Hamad Elmaghrbi (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05962632
Collaborator
Shofu Inc. (Industry)
44
4
15

Study Details

Study Description

Brief Summary

To compare the caries preventive efficacy of clinical-based, home based or E-based oral health interventions and their cost effectiveness.

Condition or Disease Intervention/Treatment Phase
  • Drug: Fluoride based varnish (Dentkist Charm Fill Varnish )
  • Drug: pro care gel remineralizing agent
  • Device: Mobile application
  • Combination Product: tooth brushing/fluoridated toothpaste over the counter 1450 ppm, interdental cleaning,fluoride rinse OTC
Early Phase 1

Detailed Description

Caries risk assessment and preventive measures have been performed over years with different perspectives without attention to budgeting and economic value and the preventive protocols remain uncertain for adults.

caries prevention, for example using fluoride varnish, has been found only limitedly cost-effective in clinic settings, which is why alternative strategies involving home-based interventions are sought .Electronic health (E-health) interventions for patient motivation and enhancing of patient adherence, for example via reminders about the reinforcement of hygiene measures and dietary counseling as well as recall visits were found to be of value This randomized controlled clinical study aims to compare the caries preventive efficacy of clinical-based, home based or E-based oral health interventions and their cost effectiveness

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
assessors will unaware of the treatment assigned to the patients therefore the assessors will not be included in the pre clinical assessment.
Primary Purpose:
Prevention
Official Title:
Efficacy and Cost-effectiveness of Different Caries Preventive Protocols in a High -Risk Group of Young Egyptian Adults: A Randomized Control Trial
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clinical-based preventive platform

applying of Fluoride varnish every 3 months

Drug: Fluoride based varnish (Dentkist Charm Fill Varnish )
topical Fluoride varnish administrated professionally every 3 months in the clinic

Experimental: Home-based preventive platform

topical remineralizing agent

Drug: pro care gel remineralizing agent
topical remineralizing agent (Surface Pre-Reacted Glass ionomer filler SPRG based)SHOFU company

Experimental: E health platform

Mobile application

Device: Mobile application
examine the impact of Mobile application on caries prevention

Active Comparator: Basic preventive measures

tooth brushing/fluoridated toothpaste over the counter 1450 ppm, interdental cleaning, fluoride rinse OTC

Combination Product: tooth brushing/fluoridated toothpaste over the counter 1450 ppm, interdental cleaning,fluoride rinse OTC
interdental cleaning(dental floss),fluoride rinse OTC (B-FRESH MOUTH WASH )

Outcome Measures

Primary Outcome Measures

  1. Caries increment [12 moths]

    number of carious tooth surfaces will be calculated ( DMFS score)will be monitored and recorded separately.

Secondary Outcome Measures

  1. Cost-Effectiveness [12 months]

    the cost effective will be calculated by the statistician (Net costs/Change in health outcome).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • High caries risk patients.

  • 18-25years.

  • Males or females.

  • Participants approving to enrol in this study.

  • Participants not enrolled in any other study.

Exclusion Criteria:

low or moderate caries risk

  • Participants with systematic conditions.

  • Patients younger than 18 years.

  • Evidence of parafunctional habits.

  • with developmental dental anomalies.

  • undergoing or will start orthodontic treatment.

  • with removable prosthesis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Roya mohamed Hamad Elmaghrbi
  • Shofu Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Roya mohamed Hamad Elmaghrbi, doctor, Cairo University
ClinicalTrials.gov Identifier:
NCT05962632
Other Study ID Numbers:
  • E&C
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Roya mohamed Hamad Elmaghrbi, doctor, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023